A Precision Oncology Platform to Support Genotype-Tailored Therapy Selection.

Abstract excerpt

There is a critical need for a streamlined process to identify genotype-matched individuals eligible for enrollment into clinical trials and/or targeted therapies, as current methodologies face challenges in integrating diverse molecular data sources. We have developed a precision oncology platform to assist molecular tumor boards and community oncologists in reviewing patients' phenotypes, evaluating related...

Topics

Join the communities discussing this publication.

• Genotype
• Medical Oncology
• Molecular Targeted Therapy
• Neoplasms
• Patient Selection